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Abstract 
Characterization of  
genomic perturbation sensitivity 
using 1000 genomes population 
 
임재현(Lim Jae Hyun) 
의학과 의과학 전공(The Department of Biomedical Sciences) 
College of Medicine  
Seoul National University  
 
Purpose: Transcriptome is perturbed by millions of genomic variants which could 
alter function of cells and phenotypes of organisms. As discovered in recent large 
Next-Generation Sequencing (NGS) project, Individual genome has at least 3 to 4 
million variants. Here, we applied perturbation network to human data from 1000 
genomes project data for interpreting genetic perturbation and characterized 
perturbation sensitive and tolerant genes.  
Methods: We integrated SIFT score of non-synonymous variants to calculate gene 
deleteriousness score and determine whether gene is perturbed or not. Perturbation 
network was constructed based on gene deleteriousness score and perturbation 
sensitivity was defined as in-degree of perturbation network. We categorized genes 
based on perturbation sensitivity and investigated evolutionarily, regulatory, and 
clinical properties of perturbation sensitive and tolerant genes.  
Results: Perturbation sensitive genes were in periphery of protein interaction 
network but evolutionarily conserved. They were regulated by less miRNA and 
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transcription factor and played a key role in cell-cell interaction. Out-degree of 
perturbation network did not show any significant biological properties. Lethal genes 
were in periphery of perturbation network and hub of protein interaction network. 
On the contrary, most disease genes were in hub of perturbation network and showed 
various trends in protein-interaction network. We drew joint network map and 
categorized disease by degree of both network.  
Conclusions: As in yeast perturbation network, perturbation sensitive genes were 
essential in survival of organism since they were evolutionarily conserved and 
related to interaction between cells. We confirmed that in-degree of perturbation 
network is better than out-degree of perturbation network for interpreting genetic 
perturbation. Disease genes can be categorized and visualized using both protein-
interaction network and perturbation network. In conclusion, perturbation sensitivity 
was valuable measure for interpreting genetic perturbation and assessing gene's 
biological and clinical properties.  
 
Key word: Genetic Perturbation, Transcriptome, Protein interaction network, 
Disease gene 
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1.1. Definition of Genetic Perturbation  
 
 Human genome is complex system with great diversity. Sequencing of individual 
genome by Next Generation Sequencing (NGS) technology reveals that each 
individual possesses at least 3 to 4 million variants  (1-3). The 1000 Genomes Project 
Consortium report genomes of 1,092 individuals sampled from 14 populations 
drawn from 4 continents. They provide validated haplotype map of 38 million single 
nucleotide polymorphisms, 1.4 million short insertions and deletions, and more than 
14,000 larger deletions. They also revealed that individuals from different 
populations have different profiles of common and rare variants distribution and not 
few of those are protein disrupting or located within transcription factor binding site.  
Moreover, MacArthur et al. (4) finds out that after stringent filtering, at least ~ 100 
genuine LoF variants are present in 'healthy' genomes. These variants cause 
structural and functional change of protein which might affect cis- or trans- gene 
expression (5-7).  
 Genetic perturbation is defined as perturbation caused by such variants whether they 
actually affect phenotypic change or not. An organism must stay in homeostasis and 
mitigate ripple effect of genetic perturbation, in common with the other kinds of 
stress like environmental change, endocrine signal, bacterial infection, even physical 
stress. Genes frequently perturbed by genetic perturbations are considered as stress-
responsive genes. Interpreting consequences of those genetic perturbation is 
important for understanding genotype-phenotype relationship. Within the framework 
of biological system, genetic perturbation consists of two components: perturbing 
genes and perturbed genes. Interpretation of genetic perturbation need to analyze 
either perturbing or perturbed genes.  
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1.2. Interpretation of genetic perturbation causing variants 
 
Most easy and direct way to understand genetic perturbation is direct annotation of 
variants. There are many traditional ways to annotate variants to predict functional 
change of protein, especially within coding regions. SIFT (8), PolyPhen (9, 10), and 
PhastCons (11) is example of classic methods for calculate variant function 
prediction score, which predict whether nonsynonymous changes are likely to have 
a deleterious effect on protein function  (12). They use sequence homology of related 
proteins to predict whether an amino acid substitution is likely to be deleterious to 
protein function based on the degree of conservation of the affected base throughout 
evolution.  
 Currently, filtering and annotating variants with reported phenotype is another 
method to interpret variants (13, 14). dbSNP (15, 16) was established by 1999 and 
contains almost all reported variants within human genome. By 2008, dbSNP build 
129 contained approximately 11 million single nucleotide polymorphisms and 3 
million short insertions and deletions. Genome-Wide Association Studies (GWAS) 
reveals many SNPs which related to complex traits as diabetes, inflammatory bowel 
disease, cancer and etc. Many studies use SNPs reported in GWAS catalog and 
dbSNP to filter out (17-19).  
 Major drawback of direct variant annotation is lack of interpretability, since gene 
is the main unit of all biological process. Without correlating variant-level annotation 
to gene-level annotation, variant itself does not have any biological meaning. Lee et 
al. (20) suggests simple but effective methods to compute gene-level deleteriousness 
score using variant-level score. They use SIFT algorithm to compute the variant 
score and define gene deleteriousness score as the geometric mean of variant scores 
for all nonsynonymous coding variants of the gene to evaluate. They utilize gene-
score scheme to pharmacogenomics area and proved robustness and effectiveness of 
their methods. We utilize that scheme to evaluate how gene is damaged by variants 
within coding region.  
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 Another important consideration is emerging multi-omics data, like transcriptome 
or methylome, with genome data to understand underlying biological link 
connecting genotype to phenotype. For example, Lappalainen et al. (21) sequenced 
mRNA and small RNA from lymphoblastoid cell line samples from 1000 genomes 
population. They infer genetic effects on the transcriptome using eQTL scheme and 
as a result, they reveal high resolution variant map which affect transcriptome. 
Although their analysis and results were similar to those of previous eQTL analysis, 
the dataset they built were important since it originated from 1000 genomes 
population. Before and after then, many eQTL analysis reveals that variants related 
to gene expression have strong tendency to affect phenotypes, especially disease (22-
25). Most eQTL analysis focus on variants that cause perturbations and 
characteristics of perturbed genes are often neglected. More importantly, most of 
eQTL analysis focus on variants located in regulatory region, not coding region. 
Therefore, eQTL can tell nothing about protein structure and function change. 
 
1.3. Interpretation of genetic perturbation using biological 
networks 
 
 Genetic perturbation not only causes single protein malfunction but also affects 
related proteins. Also, genes are not affected by single genetic perturbation but 
multiple events. Thus, systemic perspective is needed to incorporate such many-to-
many relations. Network, graph in mathematics, is used to model pairwise relations 
between objects and adopted to biology to understand the structure and the dynamics 
of the complex intercellular web of interactions underlying biological and clinical 
events (26, 27). 
 PPI network is one of the oldest and well-studied network in biology (28-32). Node 
of PPI network is protein and edge of PPI network is their physical interaction. Hub 
of PPI network is known to be essential in biological process and essential genes 
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tend to have higher degree of PPI network. For example,  Jeong et al. (29) claimed 
that lethal genes, which cause death of organism when it is disrupted, have higher 
PPI degree and located in hub of PPI network. Meanwhile, general properties of gene 
related to disease in PPI network are open to dispute. Disease genes does not show 
such strong tendency. Goh et al (30) claimed that there are no statistical relationship 
between disease and degree of PPI network. On the contrary, Ideker et al. (28) 
reported that disease genes forming a functional modular structure and has higher 
PPI degree. According to the work of Zhongming Zhao (33), cancer genes have the 
highest PPI degree followed by lethal genes, schizophrenia genes and neuro genes.  
 It is natural that PPI network is insufficient to characterize disease genes for many 
reasons. One is that since death of single cell does not trigger death of organism, 
disruption of lethal gene, mostly hub of PPI network, does not guarantee that it 
affects tissue- and higher architecture of organism. Because PPI network only 
reflects physical interaction of ‘static’ state of proteins and does not reflect cellular 
state which are extremely different because of differentiation and regulatory network. 
Especially, cell-cell interaction cannot be explained by inner-cellular protein 
network. Also, PPI network does not reflect relationship between genotype and 
transcriptome.  
eQTL network can break those limitations (34-36). eQTL network is bipartite 
directed network which nodes are variants and genes. Edges are given when a variant 
within a gene affect expression of other gene. eQTL network is powerful tool to 
predict downstream effects of many trait-associated variants (23). It reflects tissue-
specificity and cellular state (37). But still, eQTL network is indirect method to infer 
regulation and most importantly, tell nothing about protein function change of gene. 
Also, since eQTL network is built on variant-level analysis, interpretation of network 




1.4. Perturbation Network approach in Yeast  
 
 All of above mentioned methods focused on perturbing genes, not perturbed genes. 
Since cell is under strict regulation (38, 39), It is hard to say that whether a variant 
affects expression of certain gene or that gene is allowed to be affected. For example, 
tissue or cell-cycle specific regulations often change the relationships between 
variants and genes (40-42). To understand phenotypic effect of genetic perturbation, 
it is easy to evaluate perturbed genes, which reflects consequence of genetic 
perturbation after regulation and close to final functional change.  
 Perturbation network is effective way to measure how many gene's perturbed by 
certain perturbation (43, 44). Ohn et al. defined perturbation network as non-directed 
bipartite graph of two node groups; a group of 'genes' which showed significant 
changes in transcription level in the other group of 'deletion mutants' and links are 
made between nodes from each group based on the significance level assuming the 
'error model'. Perturbation sensitivity is defined as in-degree of gene node group. 
They constructed network from genome-wide transcriptional profiling study of 300 
perturbation experiments like gene deletions or drug treatments in Saccharomyces 
cerevisiae, yeast. They found out that perturbation sensitive genes are usually not 
essential, and their coding proteins have fewer physical interaction partners and more 
transcription factors bind to their upstream sequences.  
 Han et al. use same network and did more comprehensive analysis. They correlate 
perturbation network to PPI network and claimed that they are reciprocally 
correlated to each other. They found out that hub of perturbation network and PPI 
network are both evolutionarily conserved and their degree are negatively correlated. 
They also found out that PPI hubs are highly enriched with lethal genes but not 
disease genes, whereas perturbation network hubs are highly enriched with disease 
genes and not with lethal genes.  
 Perturbation network was well studied only in yeast, not human. Han et al. use yeast 
- human homolog genes to map disease genes to yeast genes but yeast - human 
６ 
homolog genes are special itself because they are highly conserved genes. Moreover, 
they only analyse in-degree of network since gene node group only have in-degree. 
Finally, disease genes are highly heterogeneous group so categorizing those genes 
into subgroups may improve the results.  As in PPI network, it is possible that 
different disease genes tend to have different centrality in perturbation network.  
 
1.5. Purpose of study 
 
In this research, we examined the perturbation sensitivity of genes and characterize 
perturbation sensitive and tolerant genes. To this end, we build a perturbation 
network using genome and transcriptome data of 1000 genomes population. 1000 
genomes populations have enough genetic perturbations to perform a macroscopic 
analysis of perturbation sensitivity (1, 4, 45-47). 421 samples from the 1000 genomes 
populations also have RNA-seq data (21). We slightly modify classical perturbation 
network to apply this model to healthy human population data. In our analysis, 
perturbation network can be simply viewed as a directed graph of genes. We adopt 
concept of gene deleteriousness score to distinguish damaged genes from normal 
genes and build perturbation network to calculate perturbation sensitivity, which 
defined as in-degree of perturbation network. We evaluated biological characteristics 
of perturbation tolerant, perturbation sensitive, and perturbation causing genes and 
compare it to PPI network. We also evaluated lethal genes and various disease genes 
using perturbation sensitivity and the PPI network degree. As a result, we 
characterize genes with respect to perturbation sensitivity and suggest measure for 
predicting phenotypic effect due to genetic perturbation.   
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2. Materials and Methods 
 
2.1. Genome and transcriptome data from 1000 genomes 
populations.  
 
The 1000 Genome Projects phase 1 dataset includes genomes of 1,026 individual 
samples from 14 subpopulations drawn from Europe, East Asia, sub-Saharan Africa 
and America. Within these samples, 462 samples from five populations have 
transcriptome data (21): the CEPH (CEU, n = 78), Finns (FIN, n = 89), British (GBR, 
n = 85), Toscano (TSI, n = 92) and Yoruba (YRI, n = 77). Overall, 421 samples have 
both genotype and transcriptome data. The genotype data were obtained from 1000 
genomes project page and transcriptome data were obtained from Geuvadis 
consortium page.  
We did functional reannotation of the variants from genotype data with VAT (48). 
We filter non-coding variants which are expected to have neutral effect on the protein 
function, and annotates the variant type using hg19 GENCODE (49) v12 as the 
genome reference. We only focus on autosomal variants and excluded variants 
located in sex chromosomes and indels. We also ruled out all synonymous variants 
and variants with 5% or less minor allele frequency for selecting common damaging 
variants. Overall, 327879 loci which at least 1 sample have nonsynonymous variants 
were included for further analysis.  
Transcriptome data were obtained from the Geuvadis RNA sequencing project. We 
considered FPKM (Fragments per kilo base of exon per million fragments mapped) 
as the expression level of each gene. We used upper quantile normalization to remove 
between sample difference. For further analysis, we only include 344 European 





1000 Genomes Phase 1 
Genotype data: ~ 35M variants 
Common nonsynonymous  
coding variants: 327879 variants 
Gene score for 16371 genes 
Variants with SIFT score: 148278 
variants  
Perturbation Sensitivity Network 
SIFT Dataset 
1000 Genomes Phase 1  
Transcriptome data  
Figure 1. Flow chart for construction of perturbation network  
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2.2. Calculating gene deleteriousness scores.  
 
To evaluate deleteriousness of variants within coding-region, we use gene 
deleteriousness score (20) to evaluate how coding region variants affects 
corresponding protein’s function. Gene deleteriousness scores was defined as the 
geometric mean of a variant score which reflects combined effect of multiple 
nonsynonymous variants within a gene. We use ANNOVAR (50) to annotate variant 
using SIFT (8) algorithms. ANNOVAR also provides other variant function 
prediction scores as PolyPhen (9), LRT (51), Mutation Taster (52), CADD (53). We 
use variants with SIFT score lower than 0.7 and 16371 genes have at least one variant 
in at least one sample. We assume that a gene is damaged when combined gene 
damaging score is lower than 0.3. 2930 genes were damaged in each person, on 
average. To confirm our score, we tested multiple hypothesis for thresholds that 
decides damaging variants and deleterious gene. we also tested other variant function 
prediction score as PolyPhen. Finally, we tested classical ways to determine 
damaging of gene, that If at least one variants with SIFT score < 0.05 within a genic 
region then we consider that gene as damaged. 
 
2.3. Construction of perturbation network.  
 
To evaluate the effect of damaging genes, we built perturbation network derived 
from genome and transcriptome data of 1000 genomes projects populations 
mentioned above. Perturbation network is a directed network, that each node 
represents a protein-coding gene and each edge represents perturbation of successor 
gene expression due to damaging of its predecessor. We used student’s t-test to infer 
relationships between nodes with python statsmodel library. Edges were given only 
if p-value < 0.001 in t-test. We summarized flow chart for construction of 
perturbation network from 1000 genomes dataset in figure 1. We define Kin, 
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perturbation sensitivity, as in-degree of perturbation network for 23722 genes which 
have transcriptome data. We also investigate out-degree of network, Kout, for 8895 
genes which satisfied criteria for t-test. Out-degree of perturbation network is 
calculated only for gene which is damaged at least 5 samples. For further analysis, 
we categorized genes to 3 groups according to Kin. Perturbation sensitive genes have 
top 10% of Kin and perturbation tolerant genes bottom 10% of Kin. Neutral genes are 
the rest.   
 
2.4. Construction of Protein Interaction Network. 
 
 Human protein-protein interaction data were retrieved from BIOGRID (54) 
(release 3.4.138). Data were processed as follows: (i) only proteins in the 
perturbation networks were used; and (ii) only interactions of the ‘physical 
association’ type were used. As a result, PPI network was built as undirected network 
with 20249 nodes and 239932 edges with a node degree range from 1 to 498.  
 
2.5. Retrieving biological information for gene annotation  
 
We retrieve biological database to evaluate properties of perturbation sensitive and 
tolerant genes. dN/dS (evolutionary rate) is the ratio of the number of non-
synonymous substitutions per non-synonymous site (dN) to the number of 
synonymous substitutions per synonymous site (dS), which can be used as an 
indicator of selective pressure acting on a protein-coding gene (55, 56). We obtained 
dN/dS values of mouse-human homolog genes from BiomaRt (57). A number of 
paralogs and miRNA for each gene were obtained from Ensembl using BiomaRt. 
Each gene has 5.95 paralogs on average. We retrieved ENCODE ChIP-Seq data from 
UCSC data portal (41). Data were consisted of transcription factors and their binding 
sites. We included transcription factors that bind to a region 10 kb above each gene 
１１ 
and used them as the number of upstream binding transcription factors for each gene. 
We also conduct gene set enrichment test using DAVID (58). 
 
2.6. Excess retention.  
 
‘Excess retention’ is defined as the degree to which genes with a certain property A 
is over- or under-represented in m-core compared with that in the whole gene groups 
(59). M-core of a graph G is defined as a maximal connected subgraph of G in which 
all vertices have a degree of at least m (43). The fraction of genes with property A in 
the whole group with N genes is EA = NA / N. If m-core contains Nm genes and the 
number of genes with property A in m-core is NmA, then the excess retention of the 




2.7. Joint network map for visualization of gene sets. 
 
To characterize and visualize gene sets using both PPI network and perturbation 
network, we draw joint network map with degree of both network. We draw grid 
diagram consists of pie charts for comparing lethal genes versus disease genes. x-
axis indicate perturbation network bins and y-axis indicate PPI network bins. We 
binned genes by degree of perturbation network in equally spaced intervals and by 
logarithms of degree of PPI network in equally spaced intervals. We also draw 
heatmap with same axis and less bin numbers, 5. We binned genes by degree of 
perturbation network in equally spaced intervals and by logarithms of degree of PPI 
network in equally spaced intervals. On average, each grid consists of 566 genes. 
Data matrix contains odd ratios for gene set of interest  
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2.8. Clinical annotation of PSN 
 
We performed enrichment analysis of perturbation network by genes with clinical 
importance. Disease genes were retrieved from the GWAS catalogue (18) and OMIM 
(60). Lethality information of the mouse genes were retrieved from the MGI project 
page (61). Human orthologs of mouse lethal genes were regarded as human lethal 
genes. Cancer genes were retrieved from the COSMIC cancer gene census list (62). 





3.1. Building Perturbation network  
 
 To construct perturbation network, we calculate gene deleteriousness score for each 
gene to determine whether function of corresponding protein has been changed. 
Gene deleteriousness score is calculated from SIFT Score using geometric mean of 
SIFT score of variants within a gene. As a result, each individual possesses 1841 
variants with SIFT score < 0.05 and 2930 genes with gene deleteriousness score < 
0.3. Figure 3(a) and 3(b) shows SIFT score and Gene score in one individual, 
HG00096. Since we assume gene deleteriousness score to 1.0 if there are no variants 
with SIFT score < 0.7, histogram of gene score shows higher proportion at bin of 1.0. 
Otherwise two histograms show similar distribution. 
 Next, we use gene deleteriousness score to construct perturbation network  
(Materials and methods.). We use t-test to determine whether gene expression is 
affected by gene deleteriousness score. Perturbation network consist of 23722 nodes 
and 504091 edges, with average degree of 21.25. All nodes are weakly connected 
with average shortest path length of 0.2, which implies that every gene is closely 
located to each other. We analyse in-degree and out-degree separately to investigate 
which genes are perturbation sensitive genes and which genes are perturbation 
causing genes. In degree of perturbation network, denoted as Kin, is ranged from 0 to 
166. On the contrary, out-degree of perturbation network, denoted as Kout, is ranged 
from 0 to 1205. Notice that only 6773 genes have out-degree due to limited sample 
size.  As shown in degree-distribution plots, Figure 3 (a), (b), both Kin and Kout shows 
log-normal distribution and p-value of shapiro-wilk test for log of Kin and Kout is 
4.76e-34 and 3.77e-14. Kin and Kout does not show statistically significant correlation. 
We also construct perturbation network with other criteria to determine whether gene 
is damaged and did same analysis which shows similar results.  
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Figure 2 Distribution of damaging score in HG00096. (a) Distribution of SIFT 




Figure 3. Histogram for log2(Kin) and log2(Kout). Both in-degree and out-degree 
follow log-normal distribution. 
１６ 
3.2. Biological properties of perturbation network   
 
 To characterize biological properties of perturbation network, we categorize genes 
with Kin to 3 groups, perturbation sensitive genes, perturbation tolerant genes, and 
others. Perturbation sensitive genes are defined as genes with top 10% of Kin and 
perturbation tolerant genes are defined as genes with bottom 10% of Kin. We use 
ANOVA for statistical testing. We also use excess retention method to investigate 
trends of biological properties among perturbation sensitivity (Materials and 
Methods). We also categorize genes with Kout to 3 groups, perturbation causing genes, 
perturbation free genes, and others. Perturbation causing genes are defined as genes 
with top 10% of Kout and perturbation free genes are defined as genes with bottom 
10% of Kout.   
 
3.2.1. Correlation between perturbation network and PPI 
network   
 
We compared Kin and Kout with Kppi, degree of PPI network. As shown in figure 4 
(a), perturbation sensitive genes have low Kppi while perturbation tolerant genes have 
high Kppi (ANOVA p-value = 3.54e-13). Figure 4 (b), Excess retention plot, also 
shows similar trends which X-axis represents Kin and Y-axis represents excess 
retention of corresponding perturbation sensitivity. Red line, which denotes hub of 
PPI network which have top 10% of Kppi, diminish along Kin. As in previous study 
with yeast perturbation network (44), Genes highly connected in the protein 
interaction network are least likely to be hubs in the perturbation network, and vice 
versa. On the contrary, Kout does not show trends in excess retention plot (Figure 4 
(d)) but ANOVA and boxplot (Figure 4 (c)) shows that Perturbation Causing genes 




Figure 4. Relation between perturbation network and PPI network. (a) boxplot for 
PS(perturbation sensitive genes), N(neutral genes), PT(perturbation tolerant genes)  
against Kppi. (b) Excess retention plot for hub of PPI network among Kin. (c) 
boxplot for PC(perturbation causing genes), N(neutral genes), PT(perturbation free 
genes)  against Kppi. (d) Excess retention plot for hub of PPI network among Kout. 
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3.2.2. Relationship of perturbation network to Evolutionary 
feature and regulatory feature    
 
 According to the ‘neutral’ theory of molecular evolution, random mutations not 
affecting fitness of the organism causes molecular level evolutionary change (64). 
Thus, proteins important for survival of the organism must have lower rate of 
evolution.  evolutionary changes at the molecular level are caused by drift and 
fixation of random mutations that do not affect the fitness of the organism. For 
example, hubs of the PPI network have lower dN/dS ratio (65). In this analysis, we 
use mouse-human ortholog dN/dS to evaluate protein evolutionary rate. As 
previously reported, Kppi shows negative correlation to dN/dS value, which implies 
hub of PPI networks tend to evolve slowly. Kin shows similar trends with Kppi, that 
perturbation sensitive genes also have low dN/dS, or evolutionarily conserved  
(Figure 5 (a), (b) ANOVA p-value = 0.023). On the other hand, Kout does not show 
any significant trends with dN/dS. Just as hubs of PPI network, perturbation sensitive 
genes have evolved slowly, and their sequence divergences are under high 
evolutionary selection pressure, which implies that they both are essential for 
survival of organism. We also analyse relationship between number of paralogs and 
network degrees. Paralogs are defined as more closely related gene family members 
caused by gene duplication and expected to perform similar function as in the 
ortholog and have similar neighbour and node degrees in PPI network and regulatory 
network (66, 67). In our analysis, Kin is positively correlated to number of paralogs. 




Figure 5. Biological properties of Kin. (a) Boxplot for dN/dS. (b) Excess retention 
plot for dN/dS. red line denotes evolutionarily conserved genes. (c) Boxplot for 
number of paralogs. (d) Excess retention plot for number of paralogs. Red line 
denotes genes with less paralogs. (e) Boxplot for miRNA targets. (f) Excess 
retention plot for miRNA targets. Red line denotes genes with less miRNA targets. 
(g) Boxplot for number of transcription factor. (h) Excess retention plot for number 
of transcription factor. Red line denotes genes with less transcription factor target.  
２０ 
  
Figure 6. Biological properties of Kout. (a) Boxplot for dN/dS. (b) Excess retention 
plot for dN/dS. red line denotes evolutionarily conserved genes. (c) Boxplot for 
number of paralogs. (d) Excess retention plot for number of paralogs. Red line 
denotes genes with less paralogs. (e) Boxplot for miRNA targets. (f) Excess 
retention plot for miRNA targets. Red line denotes genes with less miRNA targets. 
(g) Boxplot for number of transcription factor. (h) Excess retention plot for number 
of transcription factor. Red line denotes genes with less transcription factor target. 
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 miRNA is small non-coding RNA molecule which plays key role in regulation of 
gene expression (68-70). Especially, miRNA related to fine-tuning of target activity 
and coordinated regulation. Perturbation sensitive genes tend to be targeted by less 
miRNAs (Figure 5 (e), (f) ANOVA p-value = 1.10e-6). Kout does not show significant 
correlation to miRNA.  Number of upstream binding transcription factor grossly 
reflects centrality of regulatory network (41). Kin is negatively correlated to number 
of transcription factor (Figure 5 (g), (h) ANOVA p-value = 1.8e-18).  
Kout does not show any significant trends. Namely, perturbation sensitive genes are 
controlled by less transcription factor.   
 In conclusion, perturbation sensitive genes have lower PPI degree but evolutionarily 
conserved, less targeted by miRNA and transcription factor, and have many paralogs. 
On the contrary, Kout does not show any significant biological properties (Figure 6 
(a) ~ (h)). Finally, we checked robustness of biological properties of perturbation 




Figure 7. Results from various threshold of gene damaging. First row 
represents results of lower gene score, 0.1. Second row represents results of 
using SIFT score instead of gene score. Third row represents results of using 
PolyPhen score to calculate gene score. Independent from methods for 
deriving perturbation network, perturbation sensitive genes are evolutionarily 
conserved and inversely correlated to PPI network.   
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3.2.3. Functional annotation of perturbation network using 
GO terms 
 
We conduct gene set enrichment test using DAVID (58) for 3 groups of genes; genes 
with high perturbation sensitivity which are considered as perturbation sensitive 
genes, genes with low perturbation sensitivity or perturbation tolerant genes, and 
genes with high Kout which named as perturbation causing genes. Within top 20 
gene sets with respect to p-value, Perturbation causing genes are annotated as 
‘apoptosis’, ‘regulation of synaptic transmission’, ‘protein domain specific binding’, 
‘behaviour’, ‘regulation of neurological system process’, and ‘antigen receptor-
mediated signalling pathway’ with GOTERM_BP_FAT. Perturbation sensitive genes 
are annotated as ‘cell adhesion’, ‘biological adhesion’ with GOTERM_BP_FAT and 
‘extracellular region part’, ‘plasma membrane part’, ‘basement membrane’ with 
GOTERM_CC_FAT. Perturbation tolerant genes are annotated as ‘ubiquitin-
dependent protein catabolic process’, ‘M phase’, ‘mitotic cell cycle’ with 
GOTERM_BP_FAT and ‘nuclear lumen’, ‘nucleoplasm’ with GOTERM_CC_FAT. 
(Table 1 ~ 6) 
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GO:0007155~cell adhesion 1.68E-12 
GO:0022610~biological adhesion 1.76E-12 
GO:0050865~regulation of cell activation 1.89E-05 
GO:0002684~positive regulation of immune system process 5.30E-05 
GO:0016337~cell-cell adhesion 6.56E-05 
GO:0007267~cell-cell signaling 6.72E-05 
GO:0009611~response to wounding 9.68E-05 
GO:0002694~regulation of leukocyte activation 1.07E-04 
GO:0042127~regulation of cell proliferation 1.34E-04 
GO:0050867~positive regulation of cell activation 1.82E-04 
GO:0060429~epithelium development 2.20E-04 
GO:0051249~regulation of lymphocyte activation 3.02E-04 
GO:0006954~inflammatory response 3.20E-04 
GO:0044057~regulation of system process 3.65E-04 
GO:0008015~blood circulation 4.20E-04 
GO:0003013~circulatory system process 4.20E-04 
GO:0002696~positive regulation of leukocyte activation 4.37E-04 
GO:0006952~defense response 4.56E-04 
GO:0008284~positive regulation of cell proliferation 5.23E-04 









GO:0044421~extracellular region part 3.01E-12 
GO:0044459~plasma membrane part 1.98E-11 
GO:0005887~integral to plasma membrane 1.49E-08 
GO:0005886~plasma membrane 2.16E-08 
GO:0031226~intrinsic to plasma membrane 4.07E-08 
GO:0005615~extracellular space 5.45E-08 
GO:0005604~basement membrane 1.07E-07 
GO:0031012~extracellular matrix 1.19E-07 
GO:0005576~extracellular region 1.84E-07 
GO:0044420~extracellular matrix part 2.07E-07 
GO:0005578~proteinaceous extracellular matrix 6.30E-07 
GO:0009897~external side of plasma membrane 1.31E-05 
GO:0009986~cell surface 2.74E-05 
GO:0045202~synapse 3.94E-05 
GO:0000786~nucleosome 8.19E-05 
GO:0031091~platelet alpha granule 1.68E-04 
GO:0044456~synapse part 6.52E-04 
GO:0032993~protein-DNA complex 0.0010 
GO:0043235~receptor complex 0.0032 
GO:0042995~cell projection 0.0047 
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GO:0006511~ubiquitin-dependent protein catabolic process 0.0070 
GO:0000279~M phase 0.0086 
GO:0000278~mitotic cell cycle 0.0157 
GO:0000087~M phase of mitotic cell cycle 0.0164 
GO:0043009~chordate embryonic development 0.0176 
GO:0009792~embryonic development ending in birth or egg 
hatching 0.0194 
GO:0007051~spindle organization 0.0226 
GO:0051006~positive regulation of lipoprotein lipase 
activity 0.0243 
GO:0045087~innate immune response 0.0284 
GO:0000280~nuclear division 0.0294 
GO:0007067~mitosis 0.0294 
GO:0007283~spermatogenesis 0.0316 
GO:0048232~male gamete generation 0.0316 
GO:0000188~inactivation of MAPK activity 0.0340 
GO:0007049~cell cycle 0.0352 
GO:0022402~cell cycle process 0.0370 
GO:0045923~positive regulation of fatty acid metabolic 
process 0.0386 
GO:0048285~organelle fission 0.0393 
GO:0007585~respiratory gaseous exchange 0.0401 
GO:0010741~negative regulation of protein kinase cascade 0.0401 
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GO:0031981~nuclear lumen 0.0083 
GO:0005654~nucleoplasm 0.0087 
GO:0070013~intracellular organelle lumen 0.0191 
GO:0043233~organelle lumen 0.0224 
GO:0031974~membrane-enclosed lumen 0.0251 
GO:0016605~PML body 0.0309 
GO:0070652~HAUS complex 0.0321 
GO:0044451~nucleoplasm part 0.0328 
GO:0000159~protein phosphatase type 2A complex 0.0346 
GO:0005882~intermediate filament 0.0358 
GO:0000775~chromosome, centromeric region 0.0374 
GO:0045111~intermediate filament cytoskeleton 0.0412 
GO:0005694~chromosome 0.0493 
GO:0008287~protein serine/threonine phosphatase complex 0.0568 
GO:0043195~terminal button 0.0612 
GO:0005625~soluble fraction 0.0661 
GO:0044427~chromosomal part 0.0723 
GO:0016604~nuclear body 0.0875 
GO:0005819~spindle 0.0890 
GO:0031981~nuclear lumen 0.0083 
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GO:0050804~regulation of synaptic transmission 0.0092 
GO:0012501~programmed cell death 0.0094 
GO:0008219~cell death 0.0126 
GO:0016265~death 0.0136 
GO:0051969~regulation of transmission of nerve impulse 0.0137 
GO:0007610~behavior 0.0160 
GO:0031644~regulation of neurological system process 0.0167 
GO:0050851~antigen receptor-mediated signaling pathway 0.0188 
GO:0042981~regulation of apoptosis 0.0213 
GO:0043067~regulation of programmed cell death 0.0236 
GO:0010941~regulation of cell death 0.0244 
GO:0006401~RNA catabolic process 0.0256 
GO:0009057~macromolecule catabolic process 0.0286 
GO:0002429~immune response-activating cell surface 
receptor signaling pathway 0.0292 
GO:0002074~extraocular skeletal muscle development 0.0342 
GO:0002768~immune response-regulating cell surface 
receptor signaling pathway 0.0354 
GO:0043068~positive regulation of programmed cell death 0.0372 
GO:0010942~positive regulation of cell death 0.0382 
GO:0030111~regulation of Wnt receptor signaling pathway 0.0445 
２９ 




GO:0034399~nuclear periphery 0.0208 
GO:0045211~postsynaptic membrane 0.0292 
GO:0005881~cytoplasmic microtubule 0.0376 
GO:0043235~receptor complex 0.0500 
GO:0005637~nuclear inner membrane 0.0589 
GO:0044456~synapse part 0.0623 
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3.3. Clinical implication of perturbation network against PPI 
network    
 
3.3.1. Lethal genes versus disease genes  
 
 Lethal genes are known to have a strong tendency to be located at the functional 
centre of the interactome, while there has been much debate about the centrality of 
disease genes. We used perturbation sensitivity, which is reciprocal to the PPI 
network, to characterize disease genes. First, we compared disease genes versus 
lethal genes (Materials and Methods). Although disease is not specific term but 
general term for disturbance of organism homeostasis, we assume that union of 
GWAS and OMIM genes as disease genes since they have large enough group of 
disease genes.  
 We used multiple logistic regression to distinguish lethal genes and disease genes 
using Kin, Kout, and Kppi as predictors. As a result, disease genes have high Kin (p-
value = 8.63e-25, figure 11) but not correlated to Kppi. On the contrary, lethal genes 
have high Kppi (p-value = 1.76e-69, figure 10) but not correlated to Kin. We binned 
whole genes using both Kin and Kppi to draw 2-dimentional heatmap to characterize 
lethal genes and disease genes. Consistent with many previous reports (29, 33, 44) 
and result of our multiple logistic regression, lethal genes have enriched upper left 
region of heatmap which have high Kppi and low Kin. On the other hand, disease genes 
have enriched right or right upper region of heatmap which have high Kin. Figure 8 
shows summary. As a result, we can infer that disease genes are closely associated 
with perturbation sensitivity and weakly or rarely associated with degree of protein 
interaction network. We also draw grid diagram for schizophrenia genes versus lethal 




Figure 8. Joint grid diagram for lethal genes and disease genes. (A) A grid diagram 
that consists of pie charts that demonstrate the proportion of four groups of genes
(green : lethal non-disease genes, red : disease non-lethal genes, yellow : disease-
lethal genes, and grey : non-lethal non-disease genes) at each degree bin. (B~E) 
Excess retention plots for (B) Lethal genes in perturbation network core, (C) Lethal 
genes in PPI network core, (D) Disease genes in perturbation network core, (E) 
Disease genes in PPI network core. 
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Figure 9. Joint grid diagram for lethal genes and schizophrenia genes.  (A) A grid 
diagram that consists of pie charts that demonstrate the proportion of four groups of 
genes (green : lethal non-schizophrenia genes, red : schizophrenia non-lethal genes, 
yellow : schizophrenia -lethal genes, and grey : non-lethal non- schizophrenia genes) 
at each degree bin. (B~E) Excess retention plots for (B) lethal genes in perturbation 
network core, (C) lethal genes in PPI network core, (D) schizophrenia genes in 
perturbation network core, (E) schizophrenia genes in PPI network core. 
３３ 
 
Figure 10. Joint heatmap for lethal genes. Number of each cell denotes odd ratio of 





Figure 11. Joint heatmap for disease genes. Number of each cell denotes odd ratio 





Figure 12. Joint heatmap for visualizing 4 disease gene group: asthma, 
sclerosis, schizophrenia, and cancer. Number of each cell denotes odd ratio of 
corresponding disease genes. Red lines of right excess retention plot also 
indicate corresponding disease genes.  
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3.3.2. Disease gene classification using both Kppi and Kin  
 
We classify disease genes into small groups to categorize diseases with Kin and Kppi 
using heatmap and excess retention plot (Methods and Materials.). Figure 12 and 13 
shows heatmaps plotted by various disease gene groups. GWAS and OMIM consists 
of heterogeneous studies with various diseases. We consider genes as certain disease 
gene only if name of study including disease name. For example, we build asthma 
gene sets with genes which DISEASE/TRAIT column of GWAS catalogue includes 
'asthma' or 'Asthma'. We plot for well-studied disease genes : asthma, systemic 
sclerosis, schizophrenia, and cancer (Figure 12). Asthma, systemic sclerosis, 
schizophrenia genes show low Kppi and high Kin, while cancer genes from COSMIC 
tend to have high Kppi and low Kin.  
 
 We also use GAD (63), The Genetic Association Database, to categorize disease 
genes. GAD categorize disease genes by organ systems, as cardiovascular, 
neurological, metabolic, and etc. Figure 13. (a)~(p) shows heatmap and excess 
retention plot for disease genes categorized by organ systems. All categories of 
disease gene enriched in high Kin except cancer and renal genes, while Kppi is varied 
across categories. Figure 15 shows disease classification using clinical gene sets we 
used. Cancer genes, lethal genes, GAD neurological genes, and genes from OMIM 
clearly form clusters which implies similarities between those phenotypes.  
  
３７ 
Figure 13. Joint heatmap for visualizing disease gene categories classified in 
GAD. Number of each cell denotes odd ratio of corresponding disease genes. Red 
lines of right excess retention plot also indicate corresponding disease genes. 
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Figure 14. Joint heatmap for visualizing disease gene categories classified in 
GAD(continued). Number of each cell denotes odd ratio of corresponding disease 




Figure 15. Heatmap for disease classification. Each cell denotes mantel statistics of 




 Perturbation network is built from 1000 genomes population whose participants are 
declared themselves to be healthy and does not have any clinical information. There 
are numerous non-synonymous variants in normal population and little studies 
reported their effect. We integrate non-synonymous variants within genic region to 
evaluate damaging of a gene and apply it to elucidate perturbation sensitivity of 
genes. As in yeast perturbation network, Kin is reciprocally correlated to Kppi. Also, 
contrary to popular belief, perturbation sensitive genes are evolutionary conserved 
than perturbation tolerant genes. It is consistent with result from yeast data and 
implies that hub of perturbation network plays an important role in survival of 
organism as hub of PPI network. It also consistent with yeast perturbation network 
that Kin is related to disease genes, not lethal genes.  
 Different from yeast perturbation network, Kin does not follow scale-free 
distribution, but follow log-normal distribution irrelevant to the method for building 
perturbation network. It is also different from yeast perturbation network that in yeast, 
perturbation sensitive genes act as stress-responsive genes but in human, 
perturbation sensitive genes function as signalling molecule and located in cellular 
membrane or extracellular matrix. It may be caused by difference between single 
celled organism and multicellular organism. Extracellular environment of 
multicellular organism is strictly controlled and structured as cell to cell signalling 
system.  
 Previous report about topological characteristics of disease genes in PPI network 
were inconsistent, while lethal genes consistently reported as hub of PPI network. 
As we shown, most disease genes are correlated to perturbation network, not PPI 
network. Disease is not fatality of single cell but change of cell-cell interaction and 
function. Since perturbation network reflects cell’s response to external signal or 
stress, genes related to chronic systemic diseases located in hub of perturbation 
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network, not PPI network. In comparison, for example, cancer genes located in hub 
of PPI network since cancer is typical single cell disease. In our analysis, most 
disease genes tend to have high Kin and various Kppi while Cancer related genes are 
only categories of disease genes which have low Kin and extremely high Kppi. 
Although caner affect surrounding tissues, cancer itself is originated from single cell 
and evolved solely. On the other hands, most diseases do not be originated from 
single cell and does not dramatically change cell's function. For example, asthma is 
hypersensitive inflammatory disease and most related cells function as usual without 
stimulus. Though, we can infer a gene’s clinical importance using both PPI network 
and perturbation network. Genes located hub of PPI network may cause death of 
single cell while genes located hub of perturbation network may cause malfunction 
of single cell and change of response to external signal and stress.  
 We considered the genes that were most 'perturbed' to be hub of perturbation 
network, while many others (71) considered the most perturbing genes to be hubs. 
'Perturbing gene' is about how many genes are perturbed by certain gene and 
'Perturbed gene' is about how many genes perturb that gene. In our analysis, out-
degree does not have any significant biological implications. The most severely 
perturbing genes must be the essential genes and disturbance of essential genes may 
cause complete cell death, hence impacting all genes. Therefore, bias to non-lethal 
genes is inevitable. In contrast, the definition of the most perturbed genes is unbiased 
because the effect of lethal mutation can equally be applied to all genes. Also, genetic 
perturbation is mitigated by several biological mechanisms, it is impossible to 
connect genotype to phenotype directly. Rather, perturbed genes are closer to final 
consequence of genetic perturbation and may have biological and clinical 
implications.  
In this study, we figure out how transcriptome is regulated and react to perturbation 
using normal populations’ transcriptome perturbation sensitivity. Perturbation 
sensitivity genes are important for not only survival of single cell but also 
harmonious reaction to cell-cell interaction and external stress. Evolutional 
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evaluation of these genes confirm that these genes are evolutionarily conserved and 
important for survival of organism, not single cell. These genes also related to 
disease genes, especially chronic systemic disease. Perturbation sensitivity will 
supplement static character of protein interaction network and ease understanding of 
genome in network. Altogether, perturbation sensitivity is valuable measure for 
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연구 목적: 유전자의 발현은 수많은 유전체 돌연변이에 의해서 교란되며, 
이는 세포의 기능과 개체의 표현형에 큰 영향을 준다. 최근의 대규모 차세대 
염기서열분석 프로젝트에서 밝혀지고 있듯, 한사람의 유전체는 적어도 
300 만개의 돌연변이를 가지고 있는 것으로 알려져 있다. 본 논문에서는 
이러한 유전체 교란을 해석하고 교란에 민감한 유전자의 특징을 살펴보고자 
전사체 교란 네트워크를 1000 유전체 프로젝트 데이터를 통해 구성해 
보았다.  
연구 방법: 본 연구에서는 단백질 코딩 영역 내 비 동일 변이의 시프트 점수를 
종합하여 유전자 손상 정도를 평가하였다. 이를 기반으로 전사체 교란 
네트워크를 구성하고, 유전자의 내향 연결 정도를 교란 민감도로 정의하였다. 
유전자를 교란 민감도에 따라 분류하고 교란 민감 유전자와 교란 둔감 
유전자의 진화적, 생물학적, 그리고 임상적 특징을 조사하였다.  
결과: 교란 민감 유전자는 단백질 상호작용 네트워크의 변방에 위치해 
있었으나 진화적으로 보존되어 있었다. 이들은 상대적으로 적은 수의 미소 
전사체와 전사인자에 의해 조절되고 있으며, 세포 간의 상호작용에 중요한 
역할을 하고 있었다. 전사체 교란 네트워크의 외향 연결 정도는 중요한 
생물학적 의미를 가지고 있지 않았다. 치사 유전자의 경우 교란 네트워크의 
말단이면서 단백질 상호작용 네트워크의 중심부에 위치해 있었다. 반면, 
대부분의 질병 유전자들의 경우 교란 네트워크의 중심이면서 단백질 
상호작용 네트워크의 말단에 위치해 있었다. 두 네트워크를 모두 사용하여, 
질병을 분류하기 위한 연합 네트워크 도표를 그려보았다.  
결론: 효모에서의 연구와 마찬가지로, 교란 민감 유전자는 유전적으로 
보존되어 있고 세포 간의 상호작용에 관여하여 개체의 생존에 필수적이었다. 
５１ 
또한, 내향 연결정도가 외향 연결정도에 비해 유전자 교란을 해석하는데 
유용하다는 것을 확인하였다. 질병 유전자는 단백질 상호작용 네트워크와 
교란 네트워크를 동시에 활용하여 시각화 되고 분류될 수 있었다. 
결론적으로, 교란 민감도는 유전자의 생물학적 임상적 특성을 분석하고 
유전체 교란을 평가하는데 가치 있는 지표가 될 것이다.  
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